Clinical and Translational Oncology

, Volume 9, Issue 5, pp 308–316

Treatment guidelines in ovarian cancer

Authors

    • Servicio de Oncología MédicaFundación Instituto Valenciano de Oncología
  • A. Casado Herráez
    • Servicio de Oncología MédicaHospital Universitario San Carlos
  • A. Cervantes Ruipérez
    • Servicio de Hematología y Oncología MédicaHospital Clínico Universitario de Valencia
  • D. Gallardo Rincón
    • Instituto Nacional de Cancerología
  • E. García García
    • Servicio de Oncología MédicaFundación Instituto Valenciano de Oncología
  • A. González Martín
    • Servicio de Oncología MédicaHospital Ramón y Cajal
  • G. López García
    • Clínica Universitaria de Navarra
  • C. Mendiola Fernández
    • Servicio de Oncología MédicaHospital Universitario 12 de Octubre
  • B. Ojeda González
    • Servicio de Oncología MédicaHospital de la Santa Creu i Sant Pau
Special Article

DOI: 10.1007/s12094-007-0058-8

Cite this article as:
Poveda Velasco, A., Casado Herráez, A., Cervantes Ruipérez, A. et al. Clin Transl Oncol (2007) 9: 308. doi:10.1007/s12094-007-0058-8

Abstract

National and international specialists have met with the aim of writing down the guidelines for the treatment of epithelial ovarian cancer (in the Spanish Castilian language). These guidelines are based on the International Consensus that was published in English in the Annals of Oncology in 2005. This condition is the leading cause of death from gynaecological cancer in western countries. Its low rate of survival, barely 30% at 5 years, is above all due to late diagnosis and inappropriate surgery, so emphasis is put on these aspects. After describing the methodology for early detection and a scheme of surgical diagnostic procedures in view of the staging of an ovarian mass, the following therapeutic strategies will be recommended: cytoreductive surgery together with platinum chemotherapy under normal conditions, and also in the case of relapse. Likewise, very recent models of treatment focused on molecular targets are presented, and a broad section on methodology of clinical assays. As for this, co-operation among groups is crucial in order to make the conclusions of these studies valid for the development of new therapies.

Key words

Ovarian cancerTreatment guidelinesAdjuvant chemotherapySurgical procedures

Copyright information

© Feseo 2007